Efficacy of protected renal artery primary stenting in the solitary functioning kidney

Klonaris, Chris; Katsargyris, Αthanasios; Alexandrou, Andreas; Tsigris, C; Γιαννόπουλος, Αθανάσιος; Bastounis, Elias

doi:10.1016/j.jvs.2008.07.056

Cited by 10 publications

(5 citation statements)

References 48 publications

(54 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…RF was cured (7.1%), improved (50%), or stabilized (42.9%) in all 14 (100%). [ 28 ] Holden et al also reported that embolic protection did well in patients with ischemic nephropathy. At 6 months postintervention, 97% of patients demonstrated stabilization or improvement in RF.…”

Section: Discussionmentioning

confidence: 99%

Renal artery stent in solitary functioning kidneys

Liu

Zhang

et al. 2016

Medicine

View full text Add to dashboard Cite

Background:Solitary functioning kidney (SFK) is tough issue to address in clinical, mostly developed from renal artery stenosis (RAS) in adults. Although renal artery stent is widely used to help SFK patients, the efficacy of the stent is still disputable. This study is aimed at reviewing a series of SFK cases to draw a conclusion about the efficacy of renal artery stent.Methods:All related papers published in PubMed, Web of Science, EMBASE, and Cochrane Library were searched. Studies or subsets were included only if they satisfied certain criteria. The benefit rate which equaled the rate of improvement subjoining the rate of stabilization was calculated. All analyses were conducted with Stata version 12.0 (Stata Corporation, College Station, TX).Results:According to 7 papers on the efficacy of renal artery stent, 253 SFK patients were included. The result revealed that the renal artery stent could help SFK patients to improve or stabilize their renal function (RF). The benefit rate was 0.77, with 95% confidence interval between 0.72 and 0.83.Conclusions:With proper patient selection, renal artery stent could benefit SFK patients with a percentage odd of 0.77 to improve or stabilize the RF.

show abstract

Section: Discussionmentioning

confidence: 99%

Renal artery stent in solitary functioning kidneys

Liu

Zhang

et al. 2016

Medicine

View full text Add to dashboard Cite

show abstract

“…16 The response of renal function improvement was considered as cure when serum creatinine level decreased to ≤1.4 mg/dL after the procedure. 17 A decrease in the serum creatinine level of 20% or more was considered an improved. Deterioration was defined as an increase of ≥20% in the serum creatinine level after procedure.…”

Section: Methodsmentioning

confidence: 99%

“…Primary patency was defined as a PSV <2.2 m/s on duplex ultrasonography scan without any further intervention. 17 The procedure complications could include vessel perforation, clinically detectable lower extremity or visceral embolization (blue toe syndrome), pseudoaneurysms, arteriovenous fistulas, and hematomas of the femoral puncture during the hospital admission for the procedure.…”

Section: Definitionsmentioning

confidence: 99%

Safety and Efficacy of Carbon Dioxide and Intravascular Ultrasound-Guided Stenting for Renal Artery Stenosis in Patients With Chronic Renal Insufficiency

et al. 2014

View full text Add to dashboard Cite

We evaluated the feasibility, safety, and mid-term outcomes of renal artery stenting using carbon dioxide (CO₂) digital subtraction angiography and intravascular ultrasound (IVUS) for patients with renal insufficiency and significant atherosclerotic renal artery stenosis (RAS). Eighteen consecutive patients with chronic renal insufficiency underwent renal artery stenting under the guidance of CO₂ angiography and IVUS without contrast media. Renal function and blood pressure were assessed pre- and postintervention. A total of 27 de novo RAS in 18 patients (15 males; mean age: 72 ± 9 years) with renal insufficiency were treated by renal artery stenting with the combined use of the CO₂ angiography and IVUS without any procedural complications. Although the mean serum creatinine concentration preprocedure and 6 months after treatment did not change (2.7 ± 1.0-2.4 ± 1.1 mg/dL), blood pressure significantly decreased 6 months after stenting (158 ± 10-147 ± 11 mm Hg, P < .01).

show abstract

“…trial randomized participants to abciximab or placebo and demonstrated some benefit in the antiplatelet therapy 7 . This is important because analysis of particles demonstrates not just cholesterol crystals, but fibrin, thrombi and platelets as well 14,15 . In one study, patients receiving aspirin had lower captured particle counts 16 .…”

Section: What Is the Evidence?mentioning

confidence: 99%

“…In one study, patients receiving aspirin had lower captured particle counts 16 . Antiplatelet therapy was not routinely reported in the uncontrolled studies, although more recent studies included clopidogrel, aspirin or a combination in their protocols 14,17,18 . In the Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study, all participants undergoing angioplasty will receive aspirin indefinitely and clopidogrel for 4 weeks 19 .…”

Section: What Is the Evidence?mentioning

confidence: 99%